Ropes & Gray acted as counsel to Athyrium Capital Management in the formation of its $2 billion healthcare fund, Athyrium Opportunities Fund III.
The closing of the fund was announced on Dec. 4, with approximately $2.025 billion from a global investor base comprises more than 45 institutions, including public and private pension funds, endowments, foundations and sovereign wealth funds.
Athyrium Capital Management, LP (“Athyrium Capital”) is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium Capital manages funds with committed capital in excess of $3.7 billion.
Athyrium Opportunities Fund III seeks to make investments of $20 million to $300 million in commercial-stage healthcare companies in North America, Europe, Asia and Australia. The Fund invests across the healthcare sector including pharmaceuticals, medical products, diagnostics, healthcare services and healthcare information technology.
The Ropes & Gray team was led by hedge funds partner Jessica O’Mary (Picture) and included tax partner Adam Greenwood, hedge funds associate Gavin Alexander, corporate associates Christian Vareika and Chidi Oteh, and tax & benefits associate Kathryn Seevers.
Involved fees earner: Jessica Taylor O’Mary – Ropes & Gray; Gavin Alexander – Ropes & Gray; Chidi Oteh – Ropes & Gray; Christian Vareika – Ropes & Gray; Adam Greenwood – Ropes & Gray; Kathryn Seevers – Ropes & Gray;
Law Firms: Ropes & Gray;
Clients: Athyrium Capital Management;